3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Wilms Tumor
6
Osteosarcoma
6
Neuroblastoma
6
Leukemia, Myeloid, Acute
6
Glioma
6
Rhabdoid Tumor
5
Neoplasm Metastasis
5
Lymphoma, Non-Hodgkin
5
Hepatoblastoma
5
Sarcoma
4
Rhabdomyosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Multiple Myeloma
4
Medulloblastoma
4
Histiocytosis, Langerhans-Cell
4
Ependymoma
4
Colorectal Neoplasms
4
Carcinoma, Hepatocellular
4
Breast Neoplasms
4
Sarcoma, Ewing
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Myelodysplastic Syndromes
3
Lymphoma
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Central Nervous System Neoplasms
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Mouth Neoplasms
2
Melanoma
2
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
X-Rays
×
30 days
×
Clear all
No trials found.